Claudio Coracini & General Manager Brazil
CChief Executive Officer
Claudio Coracini joined GBT in 2015 as a President of the GBT’s affiliate in Brasil named United Medical. In his role, he is responsible for the entire P&L of the company leading the commercial structure, finance, regulatory affairs, human resources, medical and compliance areas. Claudio was the key driver of the transactional culture to integrate United Medical into GBT.
Claudio is a Pharma Executive with solid experience in big companies as Eli Lilly, Pfizer, Novo Nordisk and Shire Pharmaceuticals. Prior to join GBT, Claudio was responsible for the Shire start-up in Brazil and for the last 2 years with the company he was responsible for the Shire LATAM operations with revenues of U$ 220 M, focusing on Rare Disease products. Before Shire, Claudio was the Country Manager for Novo Nordisk in Brazil, Pfizer Commercial Director and worked for 21 years at Eli Lilly where he built his career starting as a Sales Representative in Sao Paulo and ending as a Commercial Director responsible for successful launches such as Zyprexa and Cialis in Brazil. During his journey with Lilly, Claudio had an international experience with the company living 4 year in the USA being responsible for the Sales Force Effectiveness in Europe and the Pre-launch Manager of Cialis for Latin America.
Claudio is a Brazilian native and holds an MBA in Marketing from the Escola Superior de Propaganda e Marketing in Sao Paulo – Brazil.
CChief Financial Officer
Leonardo has been with GBT for over nine years and has over twenty years of experience in finance, auditing and international accounting. His last position was as CFO of GBT Argentina. Before that he worked as Director at the planning and reporting corporate department in Uruguay and administrative department of GBT Argentina. Prior to joining GBT, Leonardo worked at Ernst & Young, Arthur Andersen and Telecom Argentina in Argentina. Leonardo holds an Accounting degree from Universidad de Buenos Aires and an MBA from Universidad de San Andres.
Renato De Giorgi
CChief Business Development Officer
Mr. De Giorgi joined GBT in 2015 as EVP, Business Development. In this role, he oversees the company´s business development activities, including mergers, acquisitions and licensing activities.
Mr. De Giorgi is an executive with years of experience in business development in global markets, including the U.S., Europe and emerging markets. His expertise is in Latin American markets.
Before joining GBT, he served as Chief Executive Officer of Droguería del Sud, the largest Argentinean Pharmaceutical Wholesaler. Prior to this role, he worked at Bausch + Lomb as the Regional Business Development Director for Latin America, based in Sao Paulo, Brazil.
Mr. De Giorgi also served for more than 15 years at GE, Booz & Company and Toyota, occupying different business development positions of increasing responsibility within Latin American and European markets.
Mr. De Giorgi pursued industrial engineering studies at Instituto Tecnológico de Buenos Aires and holds an MBA from Harvard Business School.
CGeneral Manager CANDEAM
Ms. Serna joined Grupo Biotoscana in 2016 as Executive Vice President Strategy and on October 2017 was announced as Executive Vice President for the Andean Region. Prior to joining GBT, Ms. Serna was the Procurement and Business Intelligence Director at LKM, where she also held the position of Controller. Previously, Ms. Serna was an executive with Advent International, focusing on M&A opportunities within Argentina, Uruguay and Chile. Ms. Serna pursued commercial business economics studies at Universidad Torcuato Di Tella (UTDT). She holds a Master in Finance from the Universidad Torcuato Di Tella.
CGeneral Manager Argentina & Head of Medical Affairs
Eduardo joined GBT in March 2017, as President of LKM and oversaw the integration with GBT after its acquisition, being promoted to Country Manager of Argentina, after the full consolidation. Prior to GBT, he held senior management positions at several pharmaceutical companies in Argentina including regional responsibilities in Searle and Pharmacia. He also has over 15 years of experience working on different positions in the healthcare market, HMOs, private equity funds, and hospitals where he was involved in clinical research activities.
Eduardo holds a Medical Doctor Degree from Universidad de Buenos Aires with a certification in Internal Medicine, an MBA from IDEA (Instituto de Desarrollo Empresarial de Argentina), Buenos Aires and a Senior Executive Program at the Columbia University School of Business, New York. He was also trained in managed care at Kaiser Permanent at Southern California Region and Harvard School of Public Health.
CCorporate Communications & IR Director
Melissa joined GBT in April 2017, as Investor Relations Manager of GBT, where she oversaw the IPO process. GBT completed its initial public offering in the Luxembourg Stock Exchange and offering of BDRs at B3 (São Paulo Stock Exchange) in July 2017. In 2019 she was promoted to Corporate Communications & Investor Relations Director. Melissa has more than 10 years of experience in Capital Markets and Investor Relations. Prior to joining GBT, she worked at MZ Group, the leading IR agency in Brazil, where she managed some of their key accounts in LatAm.
Melissa holds an International Relations degree from Universidad de Palermo in Buenos Aires and is undergoing an MBA from INSPER in São Paulo, Brazil.
CProject Management Officer
Joaquin joined GBT in 2018 as Project Manager Officer reporting directly to the CEO and has over 23 years of professional experience in the finance and project management segments. Before joining GBT, he held senior positions at Supermercados DIA, Aqua Capital, Advent International and Telecom Italia, focusing primarily on Business Development, Financial Planning and Management Control. Joaquin holds an MBA in Finance from NYU Stern School of Business, in New York, post-graduate program in Finance from Universidad del San Andres and a Bachelor of Arts in Economics from Universidad Catolica Argentina, in Buenos Aires.